US2014039046A1PendingUtilityA1

Compositions and products containing s-equol, and methods for their making

Assignee: CHILDRENS HOSP MEDICAL CENTERPriority: Jul 24, 2002Filed: Aug 28, 2013Published: Feb 6, 2014
Est. expiryJul 24, 2022(expired)· nominal 20-yr term from priority
C07D 311/58A61P 35/00A61K 9/0014A61K 2800/10A61Q 19/00A61K 36/00C07D 311/74A61K 8/498A23L 33/10A61P 5/30A61K 31/353A61K 31/352
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition for use in making commercial food and skin products comprising 5-equol or mixtures, including both a non-racemic mixture and a racemic mixture, of S-equol and R-equol. The composition can be used to make articles of commerce such as food supplements, pharmaceuticals, and medicaments. The compositions are useful in a method of delivering S-equol to a mammal to prevent or treat a disease or associated condition, including hormone-dependent diseases or conditions such as cardiovascular disease, lipid disorder, osteopenia, osteoporosis, liver disease, and acute ovarian estrogen deficiency. The S-equol enantiomer can be produced in a biological synthesis from the metabolism of an isoflavone by an organism.

Claims

exact text as granted — not AI-modified
1 - 27 . (canceled) 
     
     
         28 . A method for treating or preventing hot flashes associated with menopause in a patient, comprising administering to the patient an effective amount of a formulation comprising genistein, daidzein and equol or analogues thereof that selectively bind to estrogen receptor beta, wherein:
 (a) the formulation does not contain compounds that preferentially bind to estrogen receptor alpha;   (b) the patient is a menopausal or post-menopausal woman; and   (c) the formulation is administered in an effective amount from about 1 mg to about 100 mg.

Join the waitlist — get patent alerts

Track US2014039046A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.